Patients' background characteristics
Table 1 shows patients' background characteristics. A total of 177 tCVC insertion procedures were performed in 146 patients with a mean age of 6.27 ± 4.53 years old. Patients who required tCVC insertion had hematologic diseases (n=86, 48.6%: e.g., leukemia, lymphoma), solid tumors (n=75, 42.4%: e.g., neuroblastoma, hepatoblastoma), and other diseases (n=16, 9.0%: e.g., immunological disease, metabolic disease). Their height was 112.59 ± 32.29 cm, and their weight was 22.85 ± 14.36 kg. By weight, 100 cases (56.5%) were < 20 kg, 54 cases (30.5%) were 20-40 kg, and 23 cases (13.0%) were > 40 kg.
Clinical outcomes according to underlying disease
Table 2 shows clinical outcomes according to underlying disease. Based on the underlying disease, there were 86 cases (48.6%) in the hematologic disease group, 75 cases (42.4%) in the solid tumor group, and 16 cases (9.0%) in the others group. There were no significant differences in age, body height, body weight and operating time among the groups.
Intraoperative complications were recognized 4 cases (4.6%) in the hematologic disease group, 2 cases (2.7%) in the solid tumor group, and 3 cases (18.8%) in the others group, respectively. The intraoperative complication rate in the others group was significantly higher than the other two groups (p=0.049).
Clinical outcomes according to physicians' experience levels
Table 3 shows clinical outcomes according to physicians' experience levels. Based on the physicians' experience levels, there were 28 cases (15.8%) in the JR group, 92 (52.0%) in the SR group, and 57 (32.2%) in the BCPS group. The patients in the JR group were significantly older than the patients in the BCPS group (JR group: 8.0 years old [4.0-12.0], SR group: 5.00 years old [3.0-10.0], BCPS group: 4.0 years old [2.0-9.0]). There were no significant differences in body height or body weight among the groups. However, the JR group tended to be bigger than the BCPS group. The operation time of the BCPS group had a significantly shorter operation time than those of the other two groups (JR group: 43.5 minutes [34.0-50.5], SR group: 34.0 minutes [28.0-44.5], BCPS group: 30.0 minutes [22.0-36.0]). Intraoperative complication were recognized 1 case (3.6%) in the JR group, 6 cases (6.5%) in the SR group, and 2 cases (3.6%) in the BCPS group, respectively. But there were no significant differences in intraoperative complications among the groups (p =0.663)
Intraoperative complications
Details of cases with intraoperative complications are shown in Table 3. Intraoperative complications were observed in 6 cases (3.4%) of arterial puncture, 1 case (0.6%) of pneumothorax (pulmonary puncture suspected), 1 case (0.6%) of suspected hemothorax, and 1 case (0.6%) of over insertion of the tip (without no clinical symptom). Hemothorax was suspected because of postoperative pleural effusion. All complications, including hemothorax, improved conservatively without invasive treatment (Clavien-Dindo Classification grade I). The median age, body height, and body weight of the patients with intraoperative complications were 3 years old [0-7], 90cm [74-115], and 12.8 kg [5.6-19.7], respectively. The median operation time was 38 minutes [15-77]. The patients with intraoperative complications tended to be younger and smaller than other patients. Three cases of the others group were two insertion procedures for one patient with inflammatory bowel disease (IBD) and (case 1, 6) one patient with carnitine palmitoyl transferase II deficiency (case 7). The patient with IBD had a history of multiple temporary CV catheter insertions. Therefore, the patient had difficulty inserting the CV catheter.